Instituto de Investigação e Inovação em Saúde, Universidade do Porto
Rua Alfredo Allen, 208 4200-135 Porto, Portugal
Phone: +351 226 074 900
Email: info@i3s.up.pt
Pinho’s Lab member João Pereira was awarded the Best Poster Award at the IMMUNO-model Final Conference: Building Bridges in Cancer Immunotherapy Modelling, held from 20–22 May 2026 at the National Institute of Biology in Ljubljana, Slovenia
Pinho’s Lab researcher Henrique Fernandes-Mendes has been awarded two research grants (from SPG and SPED societies) to support his project on early-onset colorectal cancer.
Pinho’s Lab has received an honourable mention in the Basinnov Innovation Awards 2026, awarded to Catarina Azevedo, to the project GLY-CART — “Glycoengineered CAR-T Cells: a new strategy to Break Solid Tumor Resistance”.
Inês Alves has recently been awarded with an ECCO Grant!
This work will contribute to the discovery of novel mechanism and therapeutic targets at the interface of health-to-disease transition.
Pinho’s Lab is proud to announce that Daniela Oliveira has been awarded the SPR/Fresenius Grant, funded by the Portuguese Society of Rheumatology. The grant will support her PhD project, “GUT-JOINT AXIS STUDY – Antimicrobial antibodies as mediators of the gut–joint axis: the role of gut glycosylation and intestinal permeability in patients with Spondyloarthritis.”
Ângela Fernandes, a post-doctoral researcher at Pinho’s Lab, has been awarded with one of the prestigious 2025 Maria de Sousa grants. Ângela’s project will focus on neoantigen glycosylation in colorectal cancer – a type of cancer that remains particularly resistant to immunotherapies.
Eduarda Leite-Gomes, a PhD Student from Pinho’s Lab, has recently been awarded with a short-term fellowship from the Federation of European Biochemical Societies.
Pedro Cabral and Ana Campar have recently been awarded by NEDAI (Núcleo de Estudos de Doenças Auto-Imunes) at its XI National Congress, which also marked the XXX Annual Meeting of Autoimmunity in Portugal. Each was distinguished by their pioneering work in lupus nephritis and idiopathic inflammatory myopathies, respectively.
Pinho´s Lab was honoured to receive the Best Paper Award 2025 at the Annual Meeting of the Portuguese Society for Immunology (SPI – Sociedade Portuguesa de Imunologia), which took place in Lisbon last April.
Pinho’s Lab has recently been distinguished by the Mizutani Foundation for Glycoscience, receiving funding for a groundbreaking research project dedicated to harnessing glycans to improve immunotherapies for colorectal cancer (CRC).